Bellerophon Therapeutics has strengthened its drug and device development capabilities with the recent additions of Deborah A Quinn, vice president and medical lead for the INOpulse programmes and Martin Dekker as vice president of device engineering. Both are newly-created positions on the Bellerophon executive team.
Jonathan Peacock, chairman and chief executive officer of Bellerophon Therapeutics, commented, “Debbie’s significant experience leading the pulmonary arterial hypertension programme for Novartis Pharmaceuticals, combined with her tenures as a physician at Massachusetts General Hospital and Harvard Medical School, where she focused on pulmonary and critical care medicine, make her a natural choice as the medical lead of our INOpulse programmes. For his part, Martin brings to Bellerophon nearly two decades of experience in medical device development and manufacturing, most recently at Spacelabs Healthcare, where he successfully lead the development and production of numerous new products.”
Prior to joining Bellerophon, from December 2006 to April 2013, Quinn was responsible for leading global clinical trials in pulmonary arterial hypertension at Novartis, and, from 2013 to 2015, served as a medical director for Novartis’ heart failure programmes. From 1998 to 2011, Quinn was a practicing physician at Massachusetts General Hospital. In addition, she served as an instructor In medicine at Harvard Medical School from 1998 to 2006 and as a clinical assistant professor in medicine from 2006 to 2011. She has focused on caring for patients suffering from pulmonary arterial hypertension while also leading basic research in the area of pulmonary vasculature.
Dekker has more than 18 years of experience in medical device development and manufacturing in the USA, UK and the Netherlands. He joined Bellerophon from Spacelabs Healthcare, where he held several positions, including his most recent role as director of global operations engineering. During his employment with Spacelabs, Dekker was successful in leading and co-designing new products, implementing production line design enhancements and driving numerous quality/engineering improvement projects.
